[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:anti-smith":3},{"name":4,"total":5,"recruiting":6,"trials":7},"anti-Smith",5,4,[8,16,22,29,35],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07053800","Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)",[12],"Phase 2","RECRUITING","2026-08-26T02:15:42.447052Z","2026-07-05T05:32:16.729991Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07409181","A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)",[12],"2026-08-26T02:18:49.989941Z","2026-05-05T02:35:31.877860Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT07237659","Phase 1a\u002Fb Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA",[26],"Phase 1","2026-08-26T02:18:20.384845Z","2026-07-24T01:27:14.902192Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06708845","US Zamto-cel Autoimmune Diseases",[26],"2026-08-26T02:17:16.980188Z","2026-06-14T18:39:22.236937Z",{"nct_id":36,"title":37,"phases":38,"status":39,"updated_at":40,"content_modified":41},"NCT06518668","A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus",[26],"ENROLLING_BY_INVITATION","2026-08-26T02:16:04.914942Z","2026-07-05T03:45:20.249630Z"]